title: Neutralizing antibody and functional mapping of Bacillus anthracis protective antigen-The first step toward a rationally designed anthrax vaccine.
abstract: Anthrax is defined by the Centers for Disease Control and Prevention as a Category A pathogen for its potential use as a bioweapon. Current prevention treatments include Anthrax Vaccine Adsorbed (AVA). AVA is an undefined formulation of Bacillus anthracis culture supernatant adsorbed to aluminum hydroxide. It has an onerous vaccination schedule, is slow and cumbersome to produce and is slightly reactogenic. Next-generation vaccines are focused on producing recombinant forms of anthrax toxin in a well-defined formulation but these vaccines have been shown to lose potency as they are stored. In addition, studies have shown that a proportion of the antibody response against these vaccines is focused on non-functional, non-neutralizing regions of the anthrax toxin while some essential functional regions are shielded from eliciting an antibody response. Rational vaccinology is a developing field that focuses on designing vaccine antigens based on structural information provided by neutralizing antibody epitope mapping, crystal structure analysis, and functional mapping through amino acid mutations. This information provides an opportunity to design antigens that target only functionally important and conserved regions of a pathogen in order to make a more optimal vaccine product. This review provides an overview of the literature related to functional and neutralizing antibody epitope mapping of the Protective Antigen (PA) component of anthrax toxin.
authors.affiliation: Keck Graduate Institute, School of Applied Life Science, 535 Watson Dr., Claremont, CA, United States.
authors.forename: Ryan C
authors.initials: RC
authors.lastname: McComb
authors.affiliation: Keck Graduate Institute, School of Applied Life Science, 535 Watson Dr., Claremont, CA, United States. Electronic address: Mikhail_Martchenko@kgi.edu.
authors.forename: Mikhail
authors.initials: M
authors.lastname: Martchenko
mesh_terms: D022122:Anthrax Vaccines / Q000276:immunology* / Q000302:isolation & purification; D000907:Antibodies, Bacterial / Q000276:immunology*; D057134:Antibodies, Neutralizing / Q000276:immunology*; D000942:Antigens, Bacterial / Q000235:genetics / Q000276:immunology* / Q000378:metabolism*; D000992:Antitoxins / Q000276:immunology*; D001427:Bacterial Toxins / Q000235:genetics / Q000276:immunology* / Q000378:metabolism*; D004252:DNA Mutational Analysis; D018604:Epitope Mapping; D006801:Humans
chemical_list: D022122:Anthrax Vaccines; D000907:Antibodies, Bacterial; D057134:Antibodies, Neutralizing; D000942:Antigens, Bacterial; D000992:Antitoxins; D001427:Bacterial Toxins; C030325:anthrax toxin
keywords: Anthrax; Bacillus anthracis; Functional mapping; Neutralizing antibody mapping; Protective antigen; Rational vaccine design